首页 | 本学科首页   官方微博 | 高级检索  
检索        

依达拉奉联合七叶皂苷钠治疗脑出血的疗效分析
引用本文:驰欣杰,谢春香,尹大维,王永顺,王雪梅.依达拉奉联合七叶皂苷钠治疗脑出血的疗效分析[J].中国医药指南,2014(29):52-53.
作者姓名:驰欣杰  谢春香  尹大维  王永顺  王雪梅
作者单位:吉林市中心医院神经内科一疗区;吉林医药学院附属医院神经内科一疗区
摘    要:目的观察和分析依达拉奉联合七叶皂苷钠治疗脑出血的临床疗效。方法选择我院2010年至2012年接收治疗的200例脑出血患者为研究对象,将其随机分成观察组和对照组,每组100例。观察组采用依达拉奉联合七叶皂苷钠进行治疗,对照组采用常规方法治疗,观察两组患者的临床效果。结果观察组患者的NIHSS评分和ADL评分明显高于对照组,数据差异显著,具有统计学意义,P<0.01;治疗过程中两组患者均没有出现明显不良反应情况。结论依达拉奉联合七叶皂苷钠治疗脑出血的临床疗效显著,在临床治疗中值得推广应用。

关 键 词:依达拉奉  七叶皂苷钠  脑出血

Edaravone and Aescinate Treatment Cerebral Hemorrhage Efficacy
Institution:CHI Xin-jie, XIE Chun-xiang, YIN Da-wei, WANG Yong-shun, WANG Xue-mei ( Department of Neurology, Jilin Central Hospital, Jilin 132011, China, Department of Neurology, Affiliated Hospital of Jilin Medical College, Jilin 132013, China)
Abstract:Objective To observe and analyze the edaravone aescinate the clinical efifcacy of treatment of cerebral hemorrhage. Methods Our hospital from 2010 to 2012 received 200 cases of cerebral hemorrhage treated patients in this study were randomly divided into observation group and control group 100 cases, observation group edaravone conduct joint aescinate treatment, the control group with conventional methods of treatment, the clinical effects were observed. Results The patients with NIHSS score and ADL score was signiifcantly higher, data signiifcantly different, with statistical signiifcance, P<0.01;during treatment patients were no significant adverse reactions. Conclusion Edaravone combined aescin treatment of cerebral hemorrhage significant clinical efifcacy in clinical treatment should be widely applied.
Keywords:Edaravone  Aescinate  Cerebral hemorrhage
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号